ivWatch was founded by Gary Warren in 2010.

How much funding has ivWatch raised?

ivWatch has disclosed $90.5M raised across 6 rounds.

Where is ivWatch headquartered?

ivWatch is headquartered in Newport News, US.

ivWatch

Newport News, US · Founded 2010 · Virginia LLC

Find your way into ivWatch

1,491 people in our graph share verified history with the ivWatch team — schools, employers, funds. One of them is your warm intro.

Jen Wangunlockedknows Jaclyn Lautz · together at PwC (overlapped)

×3knows the team · via PwC

×8knows the team · via Intel Corporation

ivWatch develops sensors and monitoring systems that detect peripheral IV infiltrations and extravasations at early stages to prevent patient harm in hospital settings. The company serves healthcare providers and hospitals globally through direct partnerships and a network of distributors.

Digital Health Hardware Healthtech Medical Devices

Founders & leadership

ivWatch was founded in 2010 by Gary Warren.

Gary Warren inFounder, Member of the Board of ManagersGary Warren earned an engineering degree while interning at NASA, where he subsequently worked for 14 years before founding and selling a company to a public corporation. He has led multiple ventures as CEO and executive through high-growth stages in aerospace, internet infrastructure, mobile technology, and medical devices, including ivWatch, which developed an IV infiltration detection system recognized by Fast Company as a top global health innovation.

Holly Novak inExecutiveHolly Novak is an executive leader with over two decades of experience in quality assurance, regulatory affairs, and product development in the medical device, IVD, and biotech sectors. She has led quality management systems across 16 global regions and successfully obtained multiple regulatory clearances including 510(k) approvals, CE Marking, and MDSAP certification.

John ZwirschitzinExecutive

Helen Stephens inExecutiveHelen Stephens holds a nursing background and brings 15+ years of medtech industry experience, including leadership roles at ICU Medical/Smiths Medical, Vygon, Carefusion, and Alaris Medical Systems, where she developed expertise in intravenous infusion delivery systems and hospital infusion therapy standards. She serves as Executive Officer at ivWatch.

Jaclyn Lautz inExecutiveJaclyn Lautz holds a Ph.D. in Mechanical Engineering and brings over 15 years of experience in medical device development, regulatory compliance, and operations. She has led product lifecycles from concept through FDA clearance and CE marking for Class II devices, built Quality Management Systems for FDA and ISO 13485 compliance, and previously advised pharmaceutical and life sciences clients on regulatory strategy at PwC.

Erin Wendell inExecutiveErin Wendell is an Executive Officer at ivWatch with nearly 20 years of experience in marketing communications and brand strategy across healthcare, technology, consumer, sports, and retail sectors.

F. Brian Clare Jr.Executive

Melissa FireinExecutive

Gregory SchearsExecutive

MICHAEL GAHANExecutive

F. Brian Clare inExecutiveF. Brian Clare is an emergency medicine physician who has worked on early-stage healthcare companies focusing on clinical care delivery, operational efficiency, and financial performance. He serves as Executive Officer and Director at ivWatch, which develops sensors and monitoring systems to detect peripheral IV infiltrations and extravasations in hospital settings.

Chuck Egress inExecutiveChuck Egress held leadership positions at Symantec managing product development and business operations across enterprise security, gateway products, and a technology partner program, and previously worked in sales and product development roles at smaller companies before his acquisition involvement. He is now Executive Officer at ivWatch, which develops sensors and monitoring systems for detecting peripheral IV infiltrations in hospital settings.

Reported raises · per SEC filings

Form D private placements

$90.5M disclosed across 6 rounds · 2014–2024

▶$26.9MraisedSep 2024 · 16 investors · Other Health Care

Rule 506(b)